Important funding will allow world-class discovery analysis, innovation in information science and digital well being and collaborations within the Bay Space
Johnson & Johnson (NYSE: JNJ) (the Firm) at this time opened its San Francisco Bay Campus, a state-of-the-art Analysis & Growth (R&D) facility within the Bay Space, one of many world’s most established international hubs for innovation and entrepreneurship. The almost 200,000 square-foot facility will home as much as 400 workers, greater than doubling the R&D presence of Johnson & Johnson within the Bay Space. The campus bridges key scientific and technological capabilities by co-locating Janssen R&D, Johnson & Johnson Innovation and Johnson & Johnson Expertise. It would additional combine the Firm into the Bay Space innovation ecosystem to strengthen and improve collaborations with innovators to speed up development.
“Johnson & Johnson’s expanded presence within the Bay Space affirms our dedication to combining science and expertise to ship transformative healthcare options,” stated Joaquin Duato, Chief Government Officer, Johnson & Johnson. “On this campus, our gifted groups will use their numerous expertise and experience to sort out society’s biggest well being challenges to create a greater future for sufferers.”
The R&D focus on the new web site spans Janssen’s therapeutic areas and key capabilities, together with rising science and applied sciences for gene and RNA therapies, novel remedies and approaches for retinal and infectious ailments, and superior information science, together with synthetic intelligence and machine studying. Co-locating experience on the web site will allow the growth of the Firm’s world-class discovery engine and industry-leading pipeline.
“Our new state-of-the-art science facility within the Bay Space will additional strengthen our R&D capabilities and remodel how we uncover, develop and ship modern medicines quicker and extra effectively. By integrating drug discovery, information science and digital well being, we purpose to speed up the expansion of our best-in-class portfolio and ship higher well being outcomes for folks worldwide,” stated James Merson, Ph.D., Website Head, San Francisco Bay Campus and International Therapeutic Space Head, Infectious Ailments, Janssen Analysis & Growth, LLC.
The Johnson & Johnson Innovation Heart in California has facilitated investments and collaborations to speed up early-stage healthcare innovation with tutorial and {industry} companions within the Bay Space and higher California ecosystem since 2014. The San Francisco Bay Campus, together with the Firm’s JLABS @ South San Francisco , will proceed to allow the Firm to construct robust relationships with entrepreneurs, scientists and traders to help and spend money on extremely differentiated improvements that reach and enhance lives in every single place. Moreover, given the convergence of healthcare and expertise within the area, the Firm will improve its concentrate on the Johnson & Johnson Expertise group to reinforce its potential to create modern digital options to advance human well being.
Constructing on Johnson & Johnson’s long-standing dedication to make use of its experience and sources to cut back the environmental footprint of its operations, the Bay Space hub is designed as a high-performance inexperienced campus, reinforcing the Firm’s pledge to be accountable stewards in making a wholesome, extra sustainable future. The purpose is for the brand new web site to obtain Silver Management in Power & Environmental Design (LEED) certification, probably the most broadly used inexperienced constructing score system on the planet.
About Johnson & Johnson
At Johnson & Johnson, we imagine good well being is the inspiration of vibrant lives, thriving communities and ahead progress. That is why for greater than 135 years, we’ve got aimed to maintain folks properly at all ages and each stage of life. As we speak, because the world’s largest and most broadly-based healthcare firm, we’re dedicated to utilizing our attain and measurement for good. We attempt to enhance entry and affordability, create more healthy communities, and put a wholesome thoughts, physique and surroundings inside attain of everybody, in every single place. We’re mixing our coronary heart, science and ingenuity to profoundly change the trajectory of well being for humanity. Study extra at www.jnj.com . Comply with us at @JNJNews.
Concerning the Janssen Pharmaceutical Corporations of Johnson & Johnson
At Janssen, we’re making a future the place illness is a factor of the previous. We are the Pharmaceutical Corporations of Johnson & Johnson, working tirelessly to make that future a actuality for sufferers in every single place by preventing illness with science, bettering entry with ingenuity, and therapeutic hopelessness with coronary heart. We concentrate on areas of drugs the place we are able to make the largest distinction: Cardiovascular, Metabolism & Retina; Immunology; Infectious Ailments & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. Study extra at www.janssen.com . Comply with us at @JanssenGlobal. Janssen Analysis & Growth, LLC is a part of the Janssen Pharmaceutical Corporations of Johnson & Johnson.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation LLC works throughout the pharmaceutical, medical machine and shopper well being sectors to speed up early-stage, transformational options by catalyzing the very best concepts, wherever they’re on the planet. We do that by harnessing our deep scientific capabilities coupled with a variety of instruments, together with custom-made deal buildings, firm creation, incubation and startup providers, capital investments and different modern enterprise fashions that purpose to satisfy the various wants of entrepreneurs, scientists, and rising corporations. Our objective is to assist life science and well being expertise improvements thrive by means of collaboration and partnership with the worldwide ecosystem, in order that collectively we are able to change the trajectory of human well being. Meet our passionate staff of science and expertise specialists and learn to collaborate with us at www.jnjinnovation.com.
About Johnson & Johnson Expertise
Johnson & Johnson Expertise solves large issues in healthcare by means of expertise and digital innovation. Simply as medical doctors use scalpels, we use information science, algorithms, synthetic intelligence, robotics, and different digital options to remodel sufferers’ lives. From guiding sufferers by means of remedy to accelerating vaccine growth to enabling workers to work seamlessly from any location, our digital instruments infuse our merchandise with novelty, dexterity, and ease. Guided by Our Credo, we unleash the ability of expertise for good to drive higher entry, fairness, and sustainability, and to form the way forward for healthcare in the best way that solely we are able to.
Cautions Regarding Ahead-Wanting Statements
This press launch accommodates “forward-looking statements” as outlined within the Personal Securities Litigation Reform Act of 1995 relating to, amongst different issues: future working and monetary efficiency, product growth, market place and enterprise technique. The reader is cautioned to not depend on these forward-looking statements. These statements are primarily based on present expectations of future occasions. If underlying assumptions show inaccurate or identified or unknown dangers or uncertainties materialize, precise outcomes might differ materially from the expectations and projections of Janssen Analysis & Growth, LLC. Dangers and uncertainties embrace, however should not restricted to: financial elements, reminiscent of rate of interest and foreign money trade charge fluctuations; competitors, together with technological advances, new merchandise and patents attained by rivals; challenges inherent in new product analysis and growth, together with uncertainty of medical success and acquiring regulatory approvals; uncertainty of economic success for brand spanking new and current merchandise; challenges to patents; the influence of patent expirations; the flexibility of the Firm to efficiently execute strategic plans; the influence of enterprise mixtures and divestitures; manufacturing difficulties or delays, internally or throughout the provide chain; product efficacy or security issues leading to product remembers or regulatory motion; vital opposed litigation or authorities motion, together with associated to product legal responsibility claims; adjustments to relevant legal guidelines and laws, together with tax legal guidelines and international healthcare reforms; tendencies towards healthcare price containment; adjustments in habits and spending patterns of purchasers of healthcare services; monetary instability of worldwide economies and authorized techniques and sovereign danger; elevated scrutiny of the healthcare {industry} by authorities businesses; the Firm’s potential to fulfill the required situations to consummate the separation of the Firm’s Shopper Well being enterprise on a well timed foundation or in any respect; the Firm’s potential to efficiently separate the Firm’s Shopper Well being enterprise and notice the anticipated advantages from the separation; the New Shopper Well being Firm’s potential to succeed as a standalone publicly traded firm; and dangers associated to the influence of the COVID-19 international pandemic, such because the scope and period of the outbreak, authorities actions and restrictive measures carried out in response, materials delays and cancellations of medical procedures, provide chain disruptions and different impacts to the enterprise, or on the Firm’s potential to execute enterprise continuity plans on account of the COVID-19 pandemic. An extra record and descriptions of those dangers, uncertainties and different elements could be present in Johnson & Johnson’s Annual Report on Kind 10-Ok for the fiscal 12 months ended January 2, 2022, together with within the sections captioned “Cautionary Word Relating to Ahead-Wanting Statements” and “Merchandise 1A. Threat Components,” and in Johnson & Johnson’s subsequent Quarterly Reviews on Kind 10-Q and different filings with the Securities and Alternate Fee. Copies of those filings can be found on-line at www.sec.gov , www.jnj.com or on request from Johnson & Johnson. Any forward-looking assertion made on this launch speaks solely as of the date of this launch. Johnson & Johnson doesn’t undertake to replace any forward-looking assertion on account of new info or future occasions or developments.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20220920005339/en/
Media:
Jake Sargent
+1 732-524-1090
[email protected]
Rachael Jarnagin
+ 1 415-705-9023
[email protected]
Investor Relations:
Raychel Kruper
+1 732-524-6164
[email protected]
